Category: wiley retractions

Authors retract two papers on Remicade following legal battles

april_2009_ar_coverA group of Belgian researchers has retracted two decade-old papers in Arthritis & Rheumatism following an investigation and court case.

The papers involved the use of the drug infliximab — sold by Johnson & Johnson as Remicade  — to treat Sjögren’s syndrome, an auto-immune condition marked by the destruction of exocrine glands that secrete saliva and tears.

Infliximab is not approved for Sjögren’s. Although the two now-retracted studies suggested that it might be helpful, subsequent data did not support those findings.

Neither, apparently, did the studies themselves. Here’s the retraction notice (it’s a PDF): Continue reading Authors retract two papers on Remicade following legal battles

Author whose lawyers threatened Science Fraud corrects another paper

curi
Rui Curi

Rui Curi, the Brazilian scientist whose lawyers’ threats helped force the shutdown of Science-Fraud.org, has corrected another paper criticized by the site.

Here’s the correction for “Effects of moderate electrical stimulation on reactive species production by primary rat skeletal muscle cells: Cross-talk between superoxide and nitric oxide production,” in the Journal of Cellular Physiology: Continue reading Author whose lawyers threatened Science Fraud corrects another paper

Proteomics paper retracted for plagiarized figure of mysterious origin

proteomicsThe journal Proteomics has retracted a paper for a plagiarized figure — but how the authors came to possess the image in the first place remains a mystery.

Here’s the notice: Continue reading Proteomics paper retracted for plagiarized figure of mysterious origin

First author of recently retracted paper has another corrected, in J Ag Food Chem

jafcau_v061i004.inddA paper that shares a first author with a paper retracted in December has been corrected.

Late last year, we reported on a retraction in Antioxidants & Redox Signaling (ARDS) by Indika Edirisinghe, who was at the University of Rochester when the original paper was published, and colleagues. On January 17, the Journal of Agricultural and Food Chemistry published a correction to “Effect of Black Currant Anthocyanins on the Activation of Endothelial Nitric Oxide Synthase (eNOS) in Vitro in Human Endothelial Cells,” on which Edirisinghe is also first author.

His affiliation on that paper, originally published in July 2011, is the Illinois Institute of Technology. Here’s the correction: Continue reading First author of recently retracted paper has another corrected, in J Ag Food Chem

Shigeaki Kato notches fifth retraction

kato
Shigeaki Kato

An endocrinologist who resigned from the University of Tokyo last March as the university was investigating his work has retracted another paper.

Here’s the notice for the paper by corresponding author Shigeaki Kato and colleagues in the Journal of Bone and Mineral Research: Continue reading Shigeaki Kato notches fifth retraction

The 39 retractions: Stapel’s count rises again

stapel_npcIt’s getting hard to keep up. A day ago, we noted that Diederik Stapel’s retraction count had risen to 38. But later in the day, we heard about number 39, from the European Journal of Social Psychology.

Here’s the notice for “Making sense of war: Using the interpretation comparison model to understand the Iraq conflict”: Continue reading The 39 retractions: Stapel’s count rises again

Tick-borne disease paper retracted for data reuse

mvecoverMedical and Veterinary Entomology has retracted a 2010 paper by a group of German researchers who populated the article with data from previously published studies.

The article, titled “Established and emerging pathogens in Ixodes ricinus ticks collected from birds on a conservation island in the Baltic Sea,” looked at the potential role of migrating birds in the spread of tick-borne infections such as Lyme disease and babesiosis. Here’s the abstract: Continue reading Tick-borne disease paper retracted for data reuse

Former Harvard dental school researcher committed misconduct: ORI

Martin Biosse-Duplan
Martin Biosse-Duplan

Last week was a busy one at the U.S. Office of Research Integrity (ORI), at least judging by how many cases they posted. There were sanctions against researchers at Ohio State, Texas Tech, and the Gladstone Institutes, as we reported. And it turns out there was another case closed, of a former Harvard dental school research fellow, The Scientist reports.

According to the ORI, Martin Biosse-Duplan “engaged in research misconduct in research supported by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), grant R01 AR054450.”

The misconduct involved a lab presentation and two published abstracts: Continue reading Former Harvard dental school researcher committed misconduct: ORI

ORI sanctions former Texas Tech postdoc for falsification, fabrication, plagiarism

biomed chromatographyThe Office of Research Integrity (ORI) has sanctioned a former Texas Tech postdoc for using data that had actually been generated before he joined the lab in a paper as if it were new.

Shuang-Qing Zhang, according to today’s announcement by the ORI, “engaged in research misconduct by the falsification and fabrication of plagiarized data” in a paper he claimed to have written with his supervisor, Reza Mehvar, “Determination of dextra-methylprednisolone conjugate with glycine linker in rat plasma and liver by high-performance liquid chromatography and its application in pharmacokinetics,” first published online in Biomedical Chromatography in 2009. [see update at end of post]

The work was supported by the National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH), grant R01 GM069869. The ORI found that Zhang had: Continue reading ORI sanctions former Texas Tech postdoc for falsification, fabrication, plagiarism